Tagged: estrategia
- Nº 09Essay
Two Ledgers, One Laboratory
The private laboratory is a business and a clinical service. The two are not in conflict — they never were.
- Nº 08Essay
The Antibody That Half the Market Rents
Five diagnostics platforms are racing toward Alzheimer's blood testing. Two licensed the same antibody from the same small biotech. A third group hasn't entered the avenue at all.
- Nº 06Essay
The Race Nobody Can Win
Routine clinical chemistry has converged into an engineering commodity. The differentiation that actually matters has moved one floor up, into the specialised immunoassay niches where a wrong number hurts a patient.
- Nº 05Commercial Design
The Referring Physician Is Not a Contact
Most IVD organisations manage their referring-physician relationships as a sales pipeline. That is the wrong frame. The physician who sends samples is choosing a diagnostic partner — and the criteria have nothing to do with price.
- Nº 02Essay
Two Philosophies of the Analyzer
Asian and Western diagnostics are not separated by quality anymore. They are separated by what they choose to optimise — and that distinction is far more useful to a buyer.
- Nº 01Manifesto
Reading the Standard Curve
After sixteen years between Asian and Western diagnostics, I am done pretending the old map still works. Here is the question this notebook exists to answer.